首页> 外文期刊>Current neuropharmacology >Potential Metabolic and Behavioural Roles of the Putative Endo-cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding
【24h】

Potential Metabolic and Behavioural Roles of the Putative Endo-cannabinoid Receptors GPR18, GPR55 and GPR119 in Feeding

机译:假定的内源性大麻素受体GPR18,GPR55和GPR119在饲料中的潜在代谢和行为作用

获取原文
           

摘要

Endocannabinoids are ancient biomolecules involved in several cellular (e.g., metabo-lism) and physiological (e.g., eating behaviour) functions. Indeed, eating behaviour alterations inmarijuana users have led to investigate the orexigenic/anorexigenic effects of cannabinoids in ani-mal/human models. This increasing body of research suggests that the endocannabinoid systemplays an important role in feeding control. Accordingly, within the endocannabinoid system, can-nabinoid receptors, enzymes and genes represent potential therapeutic targets for dealing with mul-tiple metabolic and behavioural dysfunctions (e.g., obesity, anorexia, etc.). Paradoxically, our un-derstanding on the endocannabinoid system as a cellular mediator is yet limited. For example: (i)only two cannabinoid receptors have been classified, but they are not enough to explain the phar-macological profile of several experimental effects induced by cannabinoids; and (ii) several orphanG protein-coupled receptors (GPCRs) interact with cannabinoids and we do not know how to clas-sify them (e.g., GPR18, GPR55 and GPR119; amongst others).On this basis, the present review attempts to summarize the lines of evidence supporting the poten-tial role of GPR18, GPR55 and GPR119 in metabolism and feeding control that may explain someof the divergent effects and puzzling data related to cannabinoid research. Moreover, their therapeu-tic potential in feeding behaviour alterations will be considered.
机译:内源性大麻素是古老的生物分子,涉及多种细胞功能(例如新陈代谢)和生理功能(例如饮食行为)。确实,大麻使用者的饮食行为改变已导致研究在动物模型/人类模型中大麻素的致呕/厌食作用。越来越多的研究表明,内源性大麻素系统在喂养控制中起着重要作用。因此,在内源性大麻素系统内,大麻素受体,酶和基因代表潜在的治疗靶标,用于治疗多种代谢和行为功能障碍(例如,肥胖,厌食等)。矛盾的是,我们对内源性大麻素系统作为细胞介体的理解还很有限。例如:(i)仅对两种大麻素受体进行了分类,但它们不足以解释大麻素诱导的几种实验作用的药理学特征; (ii)几种孤儿G蛋白偶联受体(GPCR)与大麻素相互作用,我们不知道如何对其进行分类(例如GPR18,GPR55和GPR119等)。在此基础上,本综述试图总结一下支持GPR18,GPR55和GPR119在新陈代谢和进食控制中潜在作用的证据可能解释了与大麻素研究有关的一些不同作用和令人困惑的数据。此外,将考虑他们在喂养行为改变中的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号